Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal Antibodies), Cell Type (Bacteria, Yeast), Technology (Stirred SUB, Single Use Bubble Column Bioreactor), End User(Bio pharmaceutical Manufacturers) - Global Forecast to 2019

使い捨てバイオリアクターの世界市場:波誘発動使い捨てバイオリアクター、攪拌槽使い捨てバイオリアクター、使い捨て気泡塔バイオリアクター

◆タイトル:Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal Antibodies), Cell Type (Bacteria, Yeast), Technology (Stirred SUB, Single Use Bubble Column Bioreactor), End User(Bio pharmaceutical Manufacturers) - Global Forecast to 2019
◆商品コード:MAM-BT-2863
◆調査・発行会社:MarketsandMarkets
◆発行日:2014年11月3日
◆ページ数:157
◆レポート形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single UserUSD5,650 ⇒換算¥627,150見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥738,150見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥904,650見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"使い捨てバイオリアクターの世界市場:波誘発動使い捨てバイオリアクター、攪拌槽使い捨てバイオリアクター、使い捨て気泡塔バイオリアクター"について調査・分析し、イントロダクション、エグゼクティブサマリー、プレミアムインサイト、市場概観、市場の成長要因、阻害要因、市場の機会と課題、サプライチェーン分析、市場環境分析、市場の動態、技術別分析、種類別分析、需要先別分析、地域別分析、市場規模及び予測、競争状況、市場シェア分析、新製品発売、主要企業(ベンダー)分析等の情報をお届けいたします。

Developing markets such as China and India are lucrative markets for single-use bioreactors (SUB), owing to the low cost benefits offered by these nations.
The report segments the global SUB market by molecule type, type of cell, technology, end user, and region. The monoclonal antibodies (MAbs) segment accounted for the lion’s share of the global SUB market, by molecule type. However, the stem cell segment is expected to grow at the highest CAGR in the forecast period, owing to an increased focus on research in this segment.

On the basis of type of cell, the SUB market is categorized into mammalian cell, bacterial cell, yeast cell and others (insect cell and plant cell). The mammalian cell segment is expected to be the new revenue pocket in the market by type of cell. Increasing numbers of biologics are being based on mammalian cells due to their increased compatibility and bioactivity in humans.

The technology segment is subsegmented into wave-induced motion SUBs, stirred SUBs, single-use bubble column bioreactors and others (single-use reactors with vertically perforated discs and single-use hybrid reactors). Wave-induced motion SUB technology is the oldest and most widely accepted of these, which accounts for its large market share.

Research and development (R&D) of biopharmaceutical manufacturers, research institutes and contract research organizations (CROs) are the major end users of the SUB, followed by biopharmaceutical manufacturing. The large share of the R&D segment can be attributed to the wide acceptance of SUBs for small- and mid-scale biopharmaceutical manufacturing for clinical testing and R&D.
New and innovative product launches were found to be the dominant strategy adopted by key industry participants to increase their market share and cater to unmet market needs.

From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis, such as market dynamics (drivers, restraints, opportunities, and threats), winning imperatives, and burning issues. The report also offers market sizes and related growth of various segments in the industry. It also focuses on emerging and high-growth segments of the SUB market, high-growth regions, and the initiatives of respective governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the SUB market and their product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

【レポートの目次】

Table Of Contents

1 Introduction 15
1.1 Objectives Of The Study 15
1.2 Market Definition 16
1.3 Market Scope 16
1.3.1 Limitation Of The Study 16
1.3.2 Markets Covered 16
1.4 Stakeholders 17
1.5 Years Considered In The Study 18
1.6 Currency 18

2 Research Methodology 19
2.1 Market Size Estimation 20
2.2 Market Crackdown And Data Triangulation 22
2.2.1 Key Data From Secondary Sources 23
2.2.2 Key Data From Primary Sources 23
2.2.2.1 Key Industry Insights 24
2.2.3 Assumptions 24

3 Executive Summary 25

4 Premium Insights 29
4.1 Attractive Market Opportunities In The Single-Use Bioreactors Market 29
4.2 Single-Use Bioreactors Market, By Molecule Type 30
4.3 Single-Use Bioreactors Market Snapshot 31
4.4 Single-Use Bioreactor Market, By Technology 32
4.5 Single-Use Bioreactors Market, By End User 32
4.6 Lifecycle Analysis, By Region 33
4.7 Asia-Pacific To Show Quickest Growth 33

5 Market Overview 34
5.1 Introduction 35
5.2 Market Segmentation 36
5.2.1 Single-Use Bioreactors Market, By Technology 36
5.2.2 Single-Use Bioreactors Market, By Type Of Molecule 37
5.2.3 Single-Use Bioreactors Market, By Type Of Cells 37
5.2.4 Single-Use Bioreactors Market, By End User 37
5.3 Market Dynamics 38
5.3.1 Improved Returns On Investment For Small Companies And Startups 39
5.3.2 Reduced Complexity Of Automation 39
5.3.3 Ease In Cultivation Of Marine Organisms (Algae) 39
5.3.4 Positive Impact On The Environment 39
5.4 Restraints 40
5.4.1 Regulatory Concerns Related To Single-Use Bioreactors 40
5.4.2 Issues Regarding Leachables And Extractables 40
5.4.3 Difficulties In Meeting The Gmp Standards 41
5.5 Challenges 41
5.5.1 Limitations In Flexible Bioreactors 41
5.5.2 Need For Improved Single-Use Sensors 41
5.6 Opportunities 42
5.6.1 Growing Biologics Market 42
5.7 Winning Imperatives 42
5.7.1 Growing Popularity Of Subs Among Biopharmaceutical Companies Is An Evolving Trend 42
5.8 Burning Issues 42
5.8.1 Stability Of Biomolecules While Shifting From Single-Use Systems To Traditional Stainless Steel Leads To Limited Adoption Of Subs 42

6 Industry Insights 43
6.1 Industry Insights 43
6.2 Supply Chain Analysis 43
6.2.1 Key Influencers 44
6.3 Porter’S Five Forces Analysis 45
6.3.1 Threat From New Entrants 45
6.3.2 Threat From Substitutes 46
6.3.3 Bargaining Power Of Suppliers 46
6.3.4 Bargaining Power Of Buyers 46
6.3.5 Intensity Of Competitive Rivalry 46
6.4 Pestle Analysis 47
6.4.1 Political Factors 47
6.4.2 Economic Factors 47
6.4.3 Social Factors 47
6.4.4 Technological Factors 47
6.4.5 Environmental Factors 48
6.4.6 Legal Factors 48
6.5 Industry Insights 48

7 Single-Use Bioreactors Market, By Technology 49
7.1 Introduction 50
7.2 Wave-Induced Motion Single-Use Bioreactors 50
7.3 Stirred Tank Single-Use Bioreactors 52
7.4 Single-Use Bubble Column Bioreactors 53
7.5 Other Technologies 54

8 Single-Use Bioreactors Market, By Molecule Type 56
8.1 Introduction 57
8.2 Monoclonal Antibodies (Mabs) 58
8.3 Vaccines 59
8.4 Recombinant Proteins 61
8.5 Stem Cells 63
8.6 Gene Therapy 65
8.7 Others (Growth Factors, Interferons, Antisense, And Rna Interference) 66

9 Single-Use Bioreactors Market, By Type Of Cell 69
9.1 Introduction 70
9.2 Mammalian Cells 71
9.3 Bacterial Cells 73
9.4 Yeast Cells 75
9.5 Others (Insect Cells And Plant Cells) 77

10 Single-Use Bioreactors Market, By End User 79
10.1 Introduction 80
10.2 R&D Departments 82
10.3 Biopharmaceutical Manufacturers 84

11 Single-Use Bioreactors Market, By Geography 87
11.1 Introduction 88
11.2 North America 90
11.2.1 U.S. 94
11.2.2 Canada 96
11.3 Europe 98
11.3.1 Germany 102
11.3.2 U.K. 103
11.3.3 Rest Of Europe (Roe) 105
11.4 Asia-Pacific (Apac) 107
11.5 Rest Of The World (Row) 111

12 Competitive Landscape 114
12.1 Overview 114
12.2 Market Share Analysis, Global Single-Use Bioreactor Market 115
12.3 New Product Launches 117
12.4 Agreements & Partnerships 119
12.5 Acquisitions 121
12.6 Expansions 122
12.7 Other Developments 123

13 Company Profiles 124
13.1 Introduction 124
13.2 Applikon Biotechnology 125
13.3 Cellexus Limited 127
13.4 Cellution Biotech 129
13.5 Ge Healthcare (Subsidiary Of General Electric Company) 131
13.6 Merck Kgaa 135
13.7 Pall Corporation 138
13.8 Parker Hannifin Corporation 141
13.9 Pbs Biotech, Inc. 144
13.10 Sartorius Ag 146
13.11 Thermo Fisher Scientific, Inc. 149
*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

14 Appendix 152
14.1 Insights Of Industry Experts 152
14.2 Discussion Guide 152
14.3 Introducing Rt: Real-Time Market Intelligence 154
14.4 Available Customizations 156
14.5 Related Reports 156

List Of Tables

Table 1 Single-Use Bioreactors Market Size, By Technology,
2012–2019 ($Million) 50
Table 2 Wave-Induced Motion Single-Use Bioreactors Market Size, By Region, 2012–2019 ($Million) 51
Table 3 Stirred Tank Single-Use Bioreactors Market Size, By Region,
2012–2019 ($Million) 52
Table 4 Single-Use Bubble Column Bioreactors Market Size, By Region,
2012–2019 ($Million) 53
Table 5 Single-Use Bioreactors Other Technologies Market Size, By Region, 2012–2019 ($Million) 55
Table 6 Single-Use Bioreactors Market Size, By Molecule Type,
2012–2019 ($Million) 57
Table 7 Single-Use Bioreactors Monoclonal Antibodies Market Size, By Region, 2012–2019 ($Million) 58
Table 8 North America: Single-Use Bioreactors Monoclonal Antibodies Market Size, By Country, 2012–2019 ($Million) 59
Table 9 Europe: Single-Use Bioreactors Monoclonal Antibodies Market Size,
By Country, 2012–2019 ($Million) 59
Table 10 Single-Use Bioreactors Vaccines Market Size, By Region,
2012–2019 ($Million) 60
Table 11 North America: Single-Use Bioreactors Vaccines Market Size,
By Country, 2012–2019 ($Million) 60
Table 12 Europe: Single-Use Bioreactors Vaccines Market Size, By Country, 2012–2019 ($Million) 60
Table 13 Single-Use Bioreactors Recombinant Proteins Market Size,
By Region, 2012–2019 ($Million) 62
Table 14 North America: Single-Use Bioreactors Recombinant Proteins Market Size, By Country, 2012–2019 ($Million) 62
Table 15 Europe: Single-Use Bioreactors Recombinant Proteins Market Size,
By Country, 2012–2019 ($Million) 62
Table 16 Single-Use Bioreactors Stem Cells Market Size, By Region,
2012–2019 ($Million) 64
Table 17 North America: Single-Use Bioreactors Stem Cells Market Size,
By Country, 2012–2019 ($Million) 64
Table 18 Europe: Single-Use Bioreactors Stem Cells Market Size, By Country, 2012–2019 ($Million) 64
Table 19 Single-Use Bioreactors Gene Therapy Market Size, By Region,
2012–2019 ($Million) 65
Table 20 North America: Single-Use Bioreactors Gene Therapy Market Size,
By Country, 2012–2019 ($Million) 66
Table 21 Europe: Single-Use Bioreactors Gene Therapy Market Size,
By Country, 2012–2019 ($Million) 66
Table 22 Single-Use Bioreactors Other Molecules Market Size, By Region,
2012–2019 ($Million) 67
Table 23 North America: Single-Use Bioreactors Other Molecules Market Size, By Country, 2012–2019 ($Million) 68
Table 24 Europe: Single-Use Bioreactors Other Molecules Market Size,
By Country, 2012–2019 ($Million) 68
Table 25 Single-Use Bioreactors Market Size, By Type Of Cell,
2012–2019 ($Million) 70
Table 26 Single-Use Bioreactors Market Size For Mammalian Cells,
By Region, 2012–2019 ($Million) 72
Table 27 North America: Single-Use Bioreactors Market Size For Mammalian Cells, By Country, 2012–2019 ($Million) 72
Table 28 Europe: Single-Use Bioreactors Market Size For Mammalian Cells,
By Country, 2012–2019 ($Million) 73
Table 29 Single-Use Bioreactors Market Size For Bacterial Cells, By Region, 2012–2019 ($Million) 74
Table 30 North America: Single-Use Bioreactors Market Size For Bacterial Cells, By Country, 2012–2019 ($Million) 74
Table 31 Europe: Single-Use Bioreactors Market Size For Bacterial Cells,
By Country, 2012–2019 ($Million) 75
Table 32 Europe Will Continue To Lead Single-Use Bioreactors Market For Yeast Cells 75
Table 33 Single-Use Bioreactors Market Size For Yeast Cells, By Region,
2012–2019 ($Million) 76
Table 34 North America: Single-Use Bioreactors Market Size For Yeast Cells,
By Country, 2012–2019 ($Million) 76
Table 35 Europe: Single-Use Bioreactors Market Size For Yeast Cells,
By Country, 2012–2019 ($Million) 76
Table 36 Single-Use Bioreactors Market Size For Other Cells, By Region,
2012–2019 ($Million) 78
Table 37 North America: Single-Use Bioreactors Market Size For Other Cells,
By Country, 2012–2019 ($Million) 78
Table 38 Europe: Single-Use Bioreactors Market Size For Other Cells,
By Country, 2012–2019 ($Million) 78
Table 39 Single-Use Bioreactors Market Size, By End User, 2012–2019 ($Million) 81
Table 40 Single-Use Bioreactors R&D Departments Market Size, By Region,
2012–2019 ($Million) 83
Table 41 North America: Single-Use Bioreactors R&D Departments Market Size, By Country, 2012–2019 ($Million) 83
Table 42 Europe: Single-Use Bioreactors R&D Departments Market Size,
By Country, 2012–2019 ($Million) 84
Table 43 Single-Use Bioreactors Biopharmaceutical Manufacturers Market Size, By Region, 2012–2019 ($Million) 84
Table 44 North America: Single-Use Bioreactors Biopharmaceutical Manufacturers Market Size, By Country, 2012–2019 ($Million) 85
Table 45 Europe: Single-Use Bioreactors Biopharmaceutical Manufacturers Market Size, By Country, 2012–2019 ($Million) 86
Table 46 Single-Use Bioreactors Market Size, By Region, 2012–2019 ($Million) 89
Table 47 North America: Single-Use Bioreactors Market Size, By Country,
2012–2019 ($Million) 92
Table 48 North America: Single-Use Bioreactors Market Size, By Molecule Type, 2012–2019 ($Million) 92
Table 49 North America: Single-Use Bioreactors Market Size, By Type Of Cell, 2012–2019 ($Million) 93
Table 50 North America: Single-Use Bioreactors Market Size, By Technology, 2012–2019 ($Million) 93
Table 51 North America: Single-Use Bioreactors Market Size, By End User,
2012–2019 ($Million) 94
Table 52 U.S.: Single-Use Bioreactors Market Size, By Molecule Type,
2012–2019 ($Million) 95
Table 53 U.S.: Single-Use Bioreactors Market Size, By Type Of Cell,
2012–2019 ($Million) 95
Table 54 U.S.: Single-Use Bioreactors Market Size, By End User,
2012–2019 ($Million) 96
Table 55 Canada: Single-Use Bioreactors Market Size, By Molecule Type,
2012–2019 ($Million) 97
Table 56 Canada: Single-Use Bioreactors Market Size, By Type Of Cell,
2012–2019 ($Million) 97
Table 57 Canada: Single-Use Bioreactors Market Size, By End User,
2012–2019 ($Million) 98
Table 58 Europe: Single-Use Bioreactors Market Size, By Country,
2012–2019 ($Million) 100
Table 59 Europe: Single-Use Bioreactors Market Size, By Molecule Type,
2012–2019 ($Million) 100
Table 60 Europe: Single-Use Bioreactors Market Size, By Type Of Cell,
2012–2019 ($Million) 101
Table 61 Europe: Single-Use Bioreactors Market Size, By Technology,
2012–2019 ($Million) 101
Table 62 Europe: Single-Use Bioreactors Market Size, By End User,
2012–2019 ($Million) 102
Table 63 Germany: Single-Use Bioreactors Market Size, By Molecule Type,
2012–2019 ($Million) 102
Table 64 Germany: Single-Use Bioreactors Market Size, By Type Of Cell,
2012–2019 ($Million) 103
Table 65 Germany: Single-Use Bioreactors Market Size, By End User,
2012–2019 ($Million) 103
Table 66 U.K.: Single-Use Bioreactors Market Size, By Molecule Type,
2012–2019 ($Million) 104
Table 67 U.K.: Single-Use Bioreactors Market Size, By Type Of Cell,
2012–2019 ($Million) 104
Table 68 U.K.: Single-Use Bioreactors Market Size, By End User,
2012–2019 ($Million) 105
Table 69 Roe: Single-Use Bioreactors Market Size, By Molecule Type,
2012–2019 ($Million) 106
Table 70 Roe: Single-Use Bioreactors Market Size, By Type Of Cell,
2012–2019 ($Million) 106
Table 71 Roe: Single-Use Bioreactors Market Size, By End User,
2012–2019 ($Million) 107
Table 72 Other Asia-Pacific Countries And Drivers For Single-Use Bioreactors Market 108
Table 73 Apac: Single-Use Bioreactors Market Size, By Molecule Type,
2012–2019 ($Million) 109
Table 74 Apac: Single-Use Bioreactors Market Size, By Type Of Cell,
2012–2019 ($Million) 109
Table 75 Apac: Single-Use Bioreactors Market Size, By Technology,
2012–2019 ($Million) 110
Table 76 Apac: Single-Use Bioreactors Market Size, By End User,
2012–2019 ($Million) 110
Table 77 Row: Single-Use Bioreactors Market Size, By Molecule Type,
2012–2019 ($Million) 111
Table 78 Row: Single-Use Bioreactors Market Size, By Type Of Cell,
2012–2019 ($Million) 112
Table 79 Row: Single-Use Bioreactors Market Size, By Technology,
2012–2019 ($Million) 112
Table 80 Row: Single-Use Bioreactors Market Size, By End User,
2012–2019 ($Million) 113
Table 81 New Product Launches, 2011–2014 117
Table 82 Agreements & Partnerships, 2011–2014 119
Table 83 Acquisition, 2011–2014 121
Table 84 Expansion, 2011–2014 122
Table 85 Other Developments, 2011–2014 123



List Of Figures

Figure 1 Research Methodology 19
Figure 2 Market Size Estimation 21
Figure 3 Breakdown Of Primary Interviews: By Type, Company, Designation, And Region 22
Figure 4 Single-Use Bioreactors Market Snapshot, By Type Of Cells
(2014 Vs. 2019) 25
Figure 5 Single-Use Bioreactors Market, By Molecule Type 26
Figure 6 Single-Use Bioreactors Market, By Technology 27
Figure 7 Single-Use Bioreactors Market, By End User 27
Figure 8 Geographical Snapshot, 2014 28
Figure 9 Growing Biologics Market And Improved Return On Investment Will Drive Market Growth 29
Figure 10 Monoclonal Antibodies Segment To Hold Largest Market Share 30
Figure 11 North America Continues To Hold Maximum Market Share Of Single-Use Bioreactors Market 31
Figure 12 Wave-Induced Motion Bioreactor Segment Continues To Lead Sub Technology Market 32
Figure 13 Biopharmaceutical Manufacturers End-User Segment To See Highest Growth Rate From 2014–2019 32
Figure 14 Asia-Pacific Market Holds Lucrative Growth Opportunities 33
Figure 15 Asia-Pacific Will Grow At Fastest Rate In 2014-2019 33
Figure 16 Evolution Of Single-Use Bioreactors 35
Figure 17 Technological Advancements Play A Crucial Role In The Single-Use Bioreactors Market 36
Figure 18 Single-Use Bioreactors Market, By Technology 36
Figure 19 Single-Use Bioreactors Market, By Type Of Molecule 37
Figure 20 Single-Use Bioreactors Market, By Type Of Cells 37
Figure 21 Single-Use Bioreactors Market, By End User 38
Figure 22 Improved Returns On Investment Will Spur The Growth Of
The Sub Market 38
Figure 23 Supply Chain: Absence Of Guidelines Imposes Additional Burden On Sub Manufacturers 44
Figure 24 Porter’S Five Forces Analysis 45
Figure 25 Europe To Hold Largest Share Of Wave-Induced Motion Market In Forecast Period 51
Figure 26 Europe Continue To Lead The Stirred Tank Segment From 2014 To 2019 53
Figure 27 Europe To Dominate Single-Use Bubble Column Bioreactors Market In Forecast Period 54
Figure 28 North America To Account For Second-Largest Share Of The Other Technologies Segment In 2019 55
Figure 29 Monoclonal Antibodies Segment Dominates The Single-Use Bioreactors Market, By Molecule Type 57
Figure 30 Europe Will Dominate The Recombinant Proteins Market 61
Figure 31 Asia-Pacific Expected To Show Fastest Growth In Forecast Period 63
Figure 32 Europe Dominates Gene Therapy Market 65
Figure 33 Asia-Pacific To Show Highest Growth In Other Molecules Market 67
Figure 34 Mammalian Cell Segment To Dominate The Single-Use Bioreactors Market, By Type Of Cell 70
Figure 35 Europe Will Continue To Lead The Single-Use Bioreactors Market For Mammalian Cells In The Forecast Period 71
Figure 36 Bacterial Cells Segment To Emerge As Revenue Pocket For Manufacturers Of Single-Use Bioreactors In Asia-Pacific 74
Figure 37 Europe: Single-Use Bioreactors Market For Other Cells, By Country, 2012-2019 ($Million) 77
Figure 38 Broad End-User Base Of Single-Use Bioreactors Market 80
Figure 39 R&D (Cros, Biopharmaceutical Manufacturers, And Research Institutes) Segment Dominates The Single-Use Bioreactors End-User Market 81
Figure 40 Europe Will Continue To Lead The Single-Use Bioreactors Market 82
Figure 41 Europe Will Continue To Lead The Biopharmaceutical Manufacturers End-User Market 85
Figure 42 Geographic Snapshot (2014): High-Growth Markets Emerging As New Revenue Pockets 88
Figure 43 Asia-Pacific: Attractive Market For All Molecule Types For Single-Use Bioreactors 89
Figure 44 North America Market Snapshot: Government Support And Funding To Drive Demand For Single-Use Bioreactors 91
Figure 45 Europe Market Snapshot: U.K. Is The Major Segment In The European Single-Use Bioreactors Market 99
Figure 46 Apac Market Snapshot: Monoclonal Antibodies Segment To Account For Largest Share In Apac 108
Figure 47 Wave-Induced Motion Technology Segment To Witness The Highest Growth In Row 111
Figure 48 Product Innovation, And Agreements, Collaborations And Partnerships Were Key Strategies Adopted In Last Three Years 114
Figure 49 Global Single-Use Bioreactor Market Share, By Key Player, 2013 115
Figure 50 Battle For Market Share: New Product Launches And Agreements, Collaboration And Partnerships Were Key Strategies 116
Figure 51 Geographical Revenue Mix Of Top 5 Market Players 124




【レポートのキーワード】

使い捨てバイオリアクター、波誘発動使い捨てバイオリアクター、攪拌槽使い捨てバイオリアクター、使い捨て気泡塔バイオリアクター、モノクローナル抗体、ワクチン、組み換えタンパク、幹細胞、遺伝子治療、哺乳類細胞、細菌性細胞、酵母細胞

★調査レポート[使い捨てバイオリアクターの世界市場:波誘発動使い捨てバイオリアクター、攪拌槽使い捨てバイオリアクター、使い捨て気泡塔バイオリアクター] ( Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal Antibodies), Cell Type (Bacteria, Yeast), Technology (Stirred SUB, Single Use Bubble Column Bioreactor), End User(Bio pharmaceutical Manufacturers) - Global Forecast to 2019 / MAM-BT-2863) 販売に関する免責事項
[使い捨てバイオリアクターの世界市場:波誘発動使い捨てバイオリアクター、攪拌槽使い捨てバイオリアクター、使い捨て気泡塔バイオリアクター] ( Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal Antibodies), Cell Type (Bacteria, Yeast), Technology (Stirred SUB, Single Use Bubble Column Bioreactor), End User(Bio pharmaceutical Manufacturers) - Global Forecast to 2019 / MAM-BT-2863) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆